Catalyst Wire Dossier Catalyst Wire Dossier

Aflibercept

Aflibercept · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

143 regulatory and trial events tracked for Aflibercept, covering 2011-01-26 to 2026-07-29. Get the full timeline:

Most recent: Clinical Trial Results: Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema [Phase 4]

See pricing